Insulet Reports Full Year 2023 Revenue Increase of 30% (30%

Represents 8th Consecutive Year of 20% or More Constant Currency Revenue Growth

...

Related Keywords

Massachusetts , United States , America , Gregoryp Forlenza , Jim Hollingshead , Danielj Desalvo , Insulet Corporation , Diabetes Technology , Company Classic Omnipod , Drug Administration , International Omnipod , Exchange Commission , Company Term Loan , Year Financial Highlights , Quarter Financial Highlights , Freestyle Libre , Chief Executive , Customer Starts , Insulin Delivery System , Glycemic Outcomes Persist , Very Young Children , Insulin Delivery , Operating Margin Guidance , Eastern Time , Investor Relations , Omnipod Insulin Management System , Looking Statement , Convertible Senior Notes , Annual Report , Quarterly Reports , Months Ended December , Ended December , Ending December , Months Ending March , Markets ,